Printer Friendly

The bottom line.

Company                             Period   Ended    Sales

Amazys Holding AG                     1H     30-Jun    $66.1
Axon Instruments                      1H     30-Jun    $16.1
Becton Dickinson (Biosciences)        3Q     30-Jun   $178.8
Bede, plc                             1H     30-Jun     $2.6
Bioanalytical Systems                 3Q     30-Jun     $7.9
CyBioAG                               1H     30-Jun     $5.1
Genetix Group                         1H     30-Jun     $7.9
LION bioscience                       1Q     30-Jun     $6.3
MDS (Life Sciences)                   3Q     31-Jul   $199.3
MOCON                                 2Q     30-Jun     $5.1
Pharmacopeia (Software)               2Q     30-Jun    $19.1
Proterion                             2Q     30-Jun     $1.3
Renishaw                             FYE     30-Jun   $121.6
Robotic Tech. Sys. (Life Science)   6 Mos.   30-Jun    $13.2
SAES (Analytical Technologies)       2Q      30-Jun     $1.1
Smiths Group (Detection)             6mo     30-Jun   $440.3
Spectris (Process Technology)        6mo     30-Jun   $186.6
Tepnel Life Sciences                 FYE     30-Jun     $5.9

                                                 Op.
Company                             Chg.       Prof.    Chg.

Amazys Holding AG                    32.9%     $6.0    152.0%
Axon Instruments                     20.1%      N/A      N/A
Becton Dickinson (Biosciences)       14.4%    $33.9     45.1%
Bede, plc                           -40.8%    ($3.4)      NM
Bioanalytical Systems                19.7%     $0.9    177.3%
CyBioAG                              -5.9%    ($2.8)      NM
Genetix Group                       -12.8%    ($0.2)      NM
LION bioscience                     -39.7%    ($8.4)      NM
MDS (Life Sciences)                  13.3%    $40.0     17.7%
MOCON                                 3.6%     $0.9      6.6%
Pharmacopeia (Software)             -10.8%    ($3.6)      NM
Proterion                             6.0%    ($0.1)      NM
Renishaw                             30.3%    $17.2     43.2%
Robotic Tech. Sys. (Life Science)    20.9%      N/A      N/A
SAES (Analytical Technologies)      -61.3%      N/A      N/A
Smiths Group (Detection)            159.0%   $114.5    176.4%
Spectris (Process Technology)        74.4%    $10.3     64.2%
Tepnel Life Sciences                 23.8%    ($3.9)      NM

                                      Net
Company                              Prof.    Chg.

Amazys Holding AG                    $4.4    147.7%
Axon Instruments                     $0.1       NM
Becton Dickinson (Biosciences)        N/A      N/A
Bede, plc                           ($3.0)      NM
Bioanalytical Systems                $0.4     26.0%
CyBioAG                               N/A      N/A
Genetix Group                        $0.3    -70.9%
LION bioscience                     ($9.8)      NM
MDS (Life Sciences)                   N/A      N/A
MOCON                                $0.6      0.7%
Pharmacopeia (Software)               N/A      N/A
Proterion                           ($0.4)      NM
Renishaw                            $15.8     16.3%
Robotic Tech. Sys. (Life Science)     N/A      N/A
SAES (Analytical Technologies)        N/A      N/A
Smiths Group (Detection)              N/A      N/A
Spectris (Process Technology)         N/A      N/A
Tepnel Life Sciences                ($3.5)      NM

NA = not available
NM = Not meaningful
COPYRIGHT 2003 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:instrument industry; instrument industry
Publication:Instrument Business Outlook
Article Type:Illustration
Date:Sep 30, 2003
Words:386
Previous Article:Market profile: pyrolysis.
Next Article:Instrumentation M&A activity reaches new heights.
Topics:


Related Articles
The bottom line.
The bottom line.
The bottom line: data from recent industry financial reports. Dollar amounts in millions.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line.
The bottom line: data from recent industry financial reports. Dollar amounts in millions.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters